| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1542-0124(12)70085-X |
| P698 | PubMed publication ID | 17508120 |
| P2860 | cites work | Tear lipocalin: structure, function and molecular mechanisms of action | Q28179940 |
| Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses | Q28263589 | ||
| Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study | Q28270236 | ||
| Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. | Q30813799 | ||
| Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline | Q30818365 | ||
| Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy | Q31046170 | ||
| Treatment of keratoconjunctivitis sicca with topical androgen | Q31926207 | ||
| The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects | Q32143484 | ||
| Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome | Q33592784 | ||
| Dietary polyunsaturated fatty acids and inflammatory mediator production | Q33807447 | ||
| n-3 fatty acid supplements in rheumatoid arthritis | Q33807453 | ||
| Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops | Q69674155 | ||
| The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells | Q69735186 | ||
| Cytotoxicity of ophthalmic preservatives | Q69781874 | ||
| Ophthalmic solutions, the ocular surface, and a unique therapeutic artificial tear formulation | Q69972805 | ||
| Keratoconjunctivitis sicca caused by diphenoxylate hydrochloride with atropine sulfate (Lomotil) | Q70112689 | ||
| Punctal occlusion in tear deficiency syndromes | Q70549607 | ||
| Combination of a side shield with an ocular moisture chamber | Q70697349 | ||
| Artificial tear composition and promotion of recovery of the damaged corneal epithelium | Q70733251 | ||
| Quantitative videographic analysis of blinking in normal subjects and patients with dry eye | Q71098163 | ||
| Hamster flank organ hydrolase and lipase activity | Q71366297 | ||
| Evaluation of a physiological tear substitute in patients with keratoconjunctivitis sicca | Q72059039 | ||
| Human tear film electrolyte concentrations in health and dry-eye disease | Q72388245 | ||
| Effects of preservative-free artificial tear solutions on corneal epithelial structure and function | Q72624915 | ||
| Neutrophil Chemotaxis in Patients With Acne Receiving Oral Tetracycline Therapy | Q72826845 | ||
| Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca | Q72852578 | ||
| Silicone rubber contact lenses for the compromised cornea | Q72894108 | ||
| Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens | Q72998643 | ||
| Topically applied 15-(S)-HETE stimulates mucin production by corneal epithelium | Q73071768 | ||
| Evaluation of the effects of 15(S)-HETE on corneal epithelial cells: an electrophysiological and cytochemical study | Q73071777 | ||
| Preservation of corneal integrity by the mucin secretagogue 15(S)-HETE in a rabbit model of desiccation-induced dry eye | Q73071779 | ||
| Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes | Q73180482 | ||
| Rosacea: classification and treatment | Q73307313 | ||
| Quality of salivary tears following autologous submandibular gland transplantation for severe dry eye | Q73421911 | ||
| The detection of bacteria and bacterial biofilms in punctal plug holes | Q73828857 | ||
| Scleral contact lenses for overnight wear in the management of ocular surface disorders | Q73841451 | ||
| Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol | Q74089268 | ||
| Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion | Q74120740 | ||
| Rabbit conjunctival epithelium transports fluid, and P2Y2(2) receptor agonists stimulate Cl(-) and fluid secretion | Q74154149 | ||
| Prevalence of and risk factors for dry eye syndrome | Q74298539 | ||
| Retardation of wound healing in the corneal epithelium by lanolin | Q75453728 | ||
| Complications associated with silicone intracanalicular plugs | Q77418714 | ||
| Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine | Q77729873 | ||
| Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group | Q77932040 | ||
| Punctal plugs in the management of dry eyes | Q79537083 | ||
| Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy | Q80021611 | ||
| The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms | Q80933729 | ||
| An optimised protocol for the production of autologous serum eyedrops | Q81499524 | ||
| Use of antibiotics and risk of breast cancer | Q81553972 | ||
| The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction | Q82620255 | ||
| Mucin characteristics of human corneal-limbal epithelial cells that exclude the rose bengal anionic dye | Q34313371 | ||
| Effects of common ophthalmic preservatives on ocular health | Q34488195 | ||
| Entry of four tetracyclines into saliva and tears | Q34902998 | ||
| Treatment of dry eye by autologous serum application in Sjögren's syndrome | Q35309629 | ||
| Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study. | Q35552228 | ||
| Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease | Q35592019 | ||
| Oral tetracyclines for ocular rosacea: an evidence-based review of the literature | Q35618906 | ||
| Short term oral minocycline treatment of meibomianitis | Q35761865 | ||
| Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome | Q35769293 | ||
| Use of macrolides and tetracyclines for chronic inflammatory diseases | Q35962028 | ||
| Tetracyclines: nonantibiotic properties and their clinical implications | Q36380200 | ||
| JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells | Q36380244 | ||
| Compliance issues in manufacturing of drugs. | Q36639887 | ||
| Corneal cytotoxicity of topically applied drugs, vehicles and preservatives | Q36641259 | ||
| Dysfunctional tear syndrome: a Delphi approach to treatment recommendations | Q36653052 | ||
| Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines | Q36880135 | ||
| Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea | Q37309955 | ||
| Ocular rosacea | Q38171313 | ||
| Successful Treatment of Dry Mouth and Dry Eye Symptoms in Sjögren's Syndrome Patients With Oral Pilocarpine: A Randomized, Placebo-Controlled, Dose-Adjustment Study | Q39344788 | ||
| Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. | Q39386112 | ||
| Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome | Q39422825 | ||
| Transplantation of the autologous submandibular gland for most severe cases of keratoconjunctivitis sicca | Q39450621 | ||
| Spectacle side panels and moist inserts for the treatment of dry-eye patients. | Q39485003 | ||
| Efficacy of doxycycline and tetracycline in ocular rosacea. | Q39492430 | ||
| Tear diluents in the treatment of keratoconjunctivitis sicca | Q39549123 | ||
| Adverse external ocular effects of topical ophthalmic medications | Q39836600 | ||
| INTRA-CANALICULAR GELATIN IMPLANTS IN THE TREATMENT OF KERATO-CONJUNCTIVITIS SICCA. | Q39840251 | ||
| Effects of 15(S)-HETE on human conjunctival mucin secretion. | Q40667098 | ||
| Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group | Q40765221 | ||
| Dietary n-3 fatty acids and therapy for rheumatoid arthritis | Q40878936 | ||
| Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group | Q41730611 | ||
| Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca | Q41786016 | ||
| Gefarnate increases PAS positive cell density in rabbit conjunctiva | Q42134286 | ||
| Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial | Q43535290 | ||
| Ocular safety of INS365 ophthalmic solution: a P2Y(2) agonist in healthy subjects | Q43589783 | ||
| Antibiotic use in relation to the risk of breast cancer | Q43622802 | ||
| The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments | Q43637103 | ||
| The eicosanoid, 15-(S)-HETE, stimulates secretion of mucin-like glycoprotein by the corneal epithelium | Q43645513 | ||
| Controlled study of the use of autologous serum in dry eye patients. | Q43783612 | ||
| Wettability and wetting of corneal epithelium | Q43811603 | ||
| Effect of gefarnate on the ocular surface in squirrel monkeys | Q43935691 | ||
| A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca | Q43937871 | ||
| An electrolyte-based solution that increases corneal glycogen and conjunctival goblet-cell density in a rabbit model for keratoconjunctivitis sicca | Q44000520 | ||
| Classification of chronic blepharitis | Q44080317 | ||
| Corneal protection by the ocular mucin secretagogue 15(S)-HETE in a rabbit model of desiccation-induced corneal defect | Q44131960 | ||
| INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model | Q44131963 | ||
| Characterization of human ocular mucin secretion mediated by 15(S)-HETE. | Q44200701 | ||
| Novel noninvasive sensitive determination of tear volume changes in normal cats | Q44249924 | ||
| Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. | Q44327659 | ||
| Potency and duration of action of synthetic P2Y2 receptor agonists on Schirmer scores in rabbits. | Q44339173 | ||
| Gefarnate stimulates goblet cell repopulation following an experimental wound to the tarsal conjunctiva in the dry eye rabbit | Q44339193 | ||
| Minocycline effect on meibomian gland lipids in meibomianitis patients | Q44360140 | ||
| Tear Potassium Contributes to Maintenance of Corneal Thickness | Q44455669 | ||
| Cytoprotective effects of rebamipide and carteolol hydrochloride against ultraviolet B-induced corneal damage in mice. | Q44489803 | ||
| Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis. | Q44527451 | ||
| The treatment of aqueous-deficient dry eye with removable punctal plugs. A clinical and impression-cytologic study | Q44574527 | ||
| The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study | Q44600963 | ||
| Antiinflammatory therapy for dry eye. | Q44763839 | ||
| Diquafosol elicits increases in net Cl- transport through P2Y2 receptor stimulation in rabbit conjunctiva | Q44797192 | ||
| Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients | Q44819842 | ||
| Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model | Q44981253 | ||
| A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance | Q45056544 | ||
| Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. | Q45122469 | ||
| Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface | Q45158772 | ||
| The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study | Q45284543 | ||
| Punctal occlusion and topical medications for glaucoma. | Q46494481 | ||
| Dry eye treatment with eye drops that stimulate mucin production. | Q47947099 | ||
| Moisture aid during sleep for the treatment of dry eye: wet gauze eye mask. | Q48854674 | ||
| Gefarnate stimulates secretion of mucin-like glycoproteins by corneal epithelium in vitro and protects corneal epithelium from desiccation in vivo. | Q50525584 | ||
| Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. | Q50933029 | ||
| Self-reported dry eye disease across refractive modalities. | Q51454973 | ||
| Scleral contact lenses: the expanding role. | Q51526498 | ||
| Effect of environmental conditions on tear dynamics in soft contact lens wearers. | Q51640150 | ||
| Symptomatic cicatrizial occlusion of canaliculi after insertion of Herrick lacrimal plugs. | Q51803057 | ||
| Morphologic effect of hyperosmolarity on rabbit corneal epithelium. | Q52501417 | ||
| Gas-permeable scleral contact lens therapy in ocular surface disease. | Q53511908 | ||
| Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States). | Q53808130 | ||
| Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. | Q54643325 | ||
| Desiccating Stress Induces T Cell-Mediated Sjogren's Syndrome-Like Lacrimal Keratoconjunctivitis | Q61851332 | ||
| Regulation of MMP-9 production by human corneal epithelial cells. | Q64935616 | ||
| Osmolarity of Tear Microvolumes in Keratoconjunctivitis Sicca | Q67324592 | ||
| Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group | Q67567097 | ||
| Perioral dermatitis: aetiology and treatment with tetracycline | Q68498444 | ||
| The effect of doxycycline on ocular rosacea | Q69296696 | ||
| Dry eye before and after therapy with hydroxypropyl methylcellulose. Ultrastructural and cytochemical study in 20 patients | Q69618611 | ||
| The effect of wearing spectacles on the humidity of the eye | Q69661929 | ||
| P433 | issue | 2 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 163-178 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | The Ocular Surface | Q15764153 |
| P1476 | title | Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007) | |
| P478 | volume | 5 |
| Q37676992 | A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye. |
| Q41442733 | A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment |
| Q37140690 | A new look at lubrication of the ocular surface: fluid mechanics behind the blinking eyelids. |
| Q33837188 | A novel TRPM8 agonist relieves dry eye discomfort |
| Q36296284 | A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients |
| Q54222666 | A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye. |
| Q35176597 | A review on recent advances in dry eye: Pathogenesis and management |
| Q33591282 | Acupuncture for dry eye syndrome after refractive surgery: study protocol for a randomized controlled trial |
| Q38497754 | Acupuncture for dry eye: a multicentre randomised controlled trial with active comparison intervention (artificial tear drop) using a mixed method approach protocol |
| Q33552734 | Acupuncture for dry eye: a randomised controlled trial protocol |
| Q34277339 | Acupuncture for the treatment of dry eye: a multicenter randomised controlled trial with active comparison intervention (artificial teardrops). |
| Q26863317 | Acupuncture therapy is more effective than artificial tears for dry eye syndrome: evidence based on a meta-analysis |
| Q35773063 | Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease |
| Q35094304 | An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye |
| Q60961948 | An experimental study of amniotic lacrimal duct stents in the treatment of perimenopausal female rabbits with dry eye |
| Q33790701 | Analysis of Clinical Characteristics of Immune-Related Dry Eye |
| Q53081062 | Anti-Inflammatory and Anti-Apoptotic Effects of Acer Palmatum Thumb. Extract, KIOM-2015EW, in a Hyperosmolar-Stress-Induced In Vitro Dry Eye Model. |
| Q24561486 | Artificial tears potpourri: a literature review |
| Q35071714 | Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK. |
| Q33845310 | Association between high tear epidermal growth factor levels and corneal subepithelial fibrosis in dry eye conditions |
| Q58597187 | Association between tear film break up time and blink interval in visual display terminal users |
| Q36625074 | Autoimmunity at the ocular surface: pathogenesis and regulation |
| Q26773937 | Biomaterials and Tissue Engineering Strategies for Conjunctival Reconstruction and Dry Eye Treatment |
| Q38712838 | Burning Eye Syndrome: Do Neuropathic Pain Mechanisms Underlie Chronic Dry Eye? |
| Q28829105 | Cationic Thiolated Poly(aspartamide) Polymer as a Potential Excipient for Artificial Tear Formulations |
| Q42403998 | Characterization of Na+-K+-2Cl- Cotransporter Activity in Rabbit Lacrimal Gland Duct Cells. |
| Q46752293 | Children with dry eye type conditions may report less severe symptoms than adult patients |
| Q36313759 | Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study |
| Q35703130 | Clinical evaluation of the therapeutic effects of atelocollagen absorbable punctal plugs |
| Q38733230 | Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting |
| Q35647454 | Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes |
| Q41736093 | Commentary: Citicoline: A Food Beneficial for Patients Suffering from or Threated with Glaucoma |
| Q55250864 | Comparative study of 0.1% hyaluronic acid versus 0.5% carboxymethylcellulose in patients with dry eye associated with moderate keratitis or keratoconjunctivitis. |
| Q33553643 | Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis |
| Q49337437 | Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction. |
| Q87474365 | Comparison of deep anterior lamellar keratoplasty and penetrating keratoplasty with respect to postoperative corneal sensitivity and tear film function |
| Q26752848 | Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease |
| Q36173213 | Conservative treatment for late-onset bleb leaks after trabeculectomy with mitomycin C in patients with ocular surface disease. |
| Q33471033 | Corneal epithelial opacity in dysfunctional tear syndrome |
| Q59796099 | Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome |
| Q61454863 | Current Management and Treatment of Dry Eye Disease |
| Q37644776 | Current practice pattern for dry eye patients in South Korea: a multicenter study. |
| Q35572113 | Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance study |
| Q54487191 | Cyclosporine in ocular surface inflammation. |
| Q38926020 | Depression and anxiety in dry eye disease: a systematic review and meta-analysis |
| Q35717311 | Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients |
| Q26746232 | Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease |
| Q47106029 | Diagnosis and Treatment of Ocular Pain: the Ophthalmologist's Perspective |
| Q39352252 | Diagnostic procedures and management of dry eye. |
| Q40268595 | Difference in ocular surface temperature by infrared thermography in phakic and pseudophakic patients |
| Q35629673 | Diquafosol ophthalmic solution 3 %: a review of its use in dry eye. |
| Q86003031 | Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition |
| Q93109216 | Dry Eye Analysis: A Citation Network Study |
| Q57258837 | Dry Eye Disease in Chronic Graft-Versus-Host Disease: Results From a Spanish Retrospective Cohort Study |
| Q90415394 | Dry Eye Disease in Routine Rheumatology Practice |
| Q39404635 | Dry Eye Management: Targeting the Ocular Surface Microenvironment. |
| Q26747001 | Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics |
| Q34647761 | Dry eye as a mucosal autoimmune disease |
| Q36799601 | Dry eye disease and microbial keratitis: is there a connection? |
| Q34273384 | Dry eye disease: A review of diagnostic approaches and treatments |
| Q36916372 | Dry eye disease: an immune-mediated ocular surface disorder |
| Q37685316 | Dry eye management in a Sjögren's syndrome mouse model by inhibition of p38-MAPK pathway |
| Q33734208 | Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus |
| Q26852044 | Dry eye: an inflammatory ocular disease |
| Q36038395 | Dual-Polymer Drops, Contact Lens Comfort, and Lid Wiper Epitheliopathy |
| Q88086011 | Early results on the use of chitosan-N-acetylcysteine (Lacrimera®) in the management of dry eye disease of varied etiology |
| Q35865215 | Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study |
| Q97536396 | Effect of a Natural Eye Drop, Made of Plantago Ovata Mucilage on Improvement of Dry Eye Symptoms: A Randomized, Double-blind Clinical Trial |
| Q37250982 | Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity |
| Q64971616 | Effect of laser acupuncture on dry eye: A study protocol for a 2-center randomized controlled trial. |
| Q92827375 | Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study |
| Q36292520 | Effects of 3% trehalose as an adjuvant treatment after LASIK. |
| Q36692399 | Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress |
| Q88933158 | Efficacy and safety of acupuncture at a single BL1 acupoint in the treatment of moderate to severe dry eye disease: Protocol for a randomized, controlled trial |
| Q60307243 | Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study |
| Q92468052 | Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye |
| Q46025632 | Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. |
| Q36137428 | Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial |
| Q35233288 | Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A. |
| Q47137945 | Elevation of autophagy markers in Sjögren syndrome dry eye. |
| Q64069793 | Enriched environment alleviates stress-induced dry-eye through the BDNF axis |
| Q36637782 | Evaluation of the transforming growth factor-beta activity in normal and dry eye human tears by CCL-185 cell bioassay |
| Q33727595 | Fibroblast Growth Factor Receptor 2 (FGFR2) Is Required for Meibomian Gland Homeostasis in the Adult Mouse |
| Q41856636 | Five things to know about...dry eye disease |
| Q35617544 | Fixed-combination treatments for intraocular hypertension in Chinese patients - focus on bimatoprost-timolol |
| Q61799655 | Gout as a Risk Factor for Dry Eye Disease: A Population-Based Cohort Study |
| Q35030126 | Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients |
| Q36358739 | How to promote and preserve eyelid health |
| Q38187962 | Human lacrimal gland regeneration: Perspectives and review of literature |
| Q33623540 | Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life |
| Q33686417 | Image-guided evaluation and monitoring of treatment response in patients with dry eye disease |
| Q26740643 | Immunomodulation on the ocular surface: a review |
| Q36393194 | Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops |
| Q37718817 | Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study |
| Q56775795 | Knowledge, attitude, and practice of dry eye treatment by institutional Chinese physicians in Singapore |
| Q33686673 | Korean guidelines for the diagnosis and management of dry eye: development and validation of clinical efficacy. |
| Q41422798 | Lacrimal Gland Repair after Short-term Obstruction of Excretory Duct in Rabbits. |
| Q39069560 | Lifitegrast Ophthalmic Solution 5%: A Review in Dry Eye Disease |
| Q86904838 | Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye |
| Q41862908 | Lower Vitamin D Level and Distinct Tear Cytokine Profile Were Observed in Patients with Mild Dry Eye Signs but Exaggerated Symptoms |
| Q41912312 | Measurement of a multi-layered tear film phantom using optical coherence tomography and statistical decision theory |
| Q36097249 | Metabolic syndrome risk factors and dry eye syndrome: a Meta-analysis |
| Q35799409 | Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution |
| Q35085293 | Neurostimulation of the lacrimal nerve for enhanced tear production |
| Q42777937 | No consequences of dietary n-3 polyunsaturated fatty acid deficiency on the severity of scopolamine-induced dry eye. |
| Q34646765 | Noninvasive assessment of tear stability with the tear stability analysis system in tear dysfunction patients |
| Q47228449 | Novel Insight Into the Role of CFTR in Lacrimal Gland Duct Function in Mice |
| Q35163639 | Nutritional supplements for dry eye syndrome |
| Q36151353 | Observation of Influence of Cataract Surgery on the Ocular Surface |
| Q35049903 | Ocular complications of diabetes mellitus |
| Q35015847 | Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial |
| Q38774962 | Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice |
| Q24198944 | Omega-3 and omega-6 polyunsaturated fatty acids for dry eye syndrome |
| Q36786949 | Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study |
| Q33623447 | Ophthalmologist perceptions regarding treatment of moderate to severe dry eye: results of a physician survey. |
| Q35542678 | Optimizing evaluation of Lissamine Green parameters for ocular surface staining. |
| Q50991094 | Osmoprotective effects of supplemental epidermal growth factor in an ex vivo multilayered human conjunctival model under hyperosmotic stress. |
| Q24186110 | Over the counter (OTC) artificial tear drops for dry eye syndrome |
| Q24203616 | Over the counter (OTC) artificial tear drops for dry eye syndrome |
| Q36444344 | PERSIST: Physician's Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review |
| Q35010238 | Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfaction |
| Q35592890 | Patient satisfaction with glaucoma therapy: reality or myth? |
| Q37284729 | Preliminary effects of oral uridine on the ocular surface in dry eye patients |
| Q35979980 | Protective Effects of L-Carnitine Against Oxidative Injury by Hyperosmolarity in Human Corneal Epithelial Cells |
| Q34682290 | Punctal occlusion for dry eye syndrome |
| Q36222687 | Relationship between symptoms of dry eye syndrome and occupational characteristics: the Korean National Health and Nutrition Examination Survey 2010-2012. |
| Q43119649 | Relevance of Lipid-Based Products in the Management of Dry Eye Disease |
| Q64899282 | Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients. |
| Q33825538 | Safety and efficacy of cyclosporine in the treatment of chronic dry eye. |
| Q58738534 | Severity of Sjögren's Syndrome Keratoconjunctivitis Sicca Increases with Increased Percentage of Conjunctival Antigen-Presenting Cells |
| Q37900496 | Systane lubricant eye drops in the management of ocular dryness |
| Q93157135 | Systematic review of the appropriateness of eye care delivery in eye care practice |
| Q35699085 | Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops |
| Q55174805 | Tear Volume-based Diagnostic Classification for Tear Dysfunction. |
| Q36637791 | Tear cytokine profiles in dysfunctional tear syndrome. |
| Q36864045 | The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study |
| Q28547448 | The Effect of Tear Supplementation on Ocular Surface Sensations during the Interblink Interval in Patients with Dry Eye |
| Q41405231 | The Prospective Health Assessment of Cataract Patients' Ocular Surface (PHACO) study: the effect of dry eye. |
| Q49925651 | The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report. |
| Q34005463 | The effects of mild ocular surface stimulation and concentration on spontaneous blink parameters |
| Q34769313 | The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee |
| Q34769319 | The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction |
| Q39820355 | The leaves of Diospyros kaki exert beneficial effects on a benzalkonium chloride-induced murine dry eye model |
| Q28083825 | The pathophysiology, diagnosis, and treatment of dry eye disease |
| Q38901538 | The potential role of neuropathic mechanisms in dry eye syndromes |
| Q37569862 | The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals |
| Q38270449 | The role and treatment of inflammation in dry eye disease |
| Q37143007 | The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye. |
| Q35682044 | Tolerability and acceptability of Blephagel: a novel eyelid hygiene aqueous gel. |
| Q35087001 | Topical cyclosporine a for treatment of dry eye due to chronic mustard gas injury |
| Q36009560 | Topical fluorometholone treatment for ocular dryness in patients with Sjögren syndrome: a randomized clinical trial in China |
| Q36099684 | Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model. |
| Q46443810 | Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist |
| Q88884763 | [Diagnosis and treatment of the watering eye] |
Search more.